Global Pharmaceutical CDMO Services Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pharmaceutical CDMO Services market report explains the definition, types, applications, major countries, and major players of the Pharmaceutical CDMO Services market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • AMRI Global

    • Piramal Pharma Solutions

    • Patheon NV

    • Aenova Group

    • WuXi AppTec Group

    • Strides Pharma Science Limited

    • Fareva Group

    • Siegfried Ltd

    • Catalent Inc

    • FAMAR Health Care Services

    • Amatsigroup

    • Recipharm AB

    By Type:

    • Drug Substance Development and Manufacturing

    • Specialized Services

    • Lab-based Services

    By End-User:

    • Innovative Medicine

    • Patented Drug

    • Patent Expired Drug

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pharmaceutical CDMO Services Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pharmaceutical CDMO Services Outlook to 2028- Original Forecasts

    • 2.2 Pharmaceutical CDMO Services Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pharmaceutical CDMO Services Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pharmaceutical CDMO Services Market- Recent Developments

    • 6.1 Pharmaceutical CDMO Services Market News and Developments

    • 6.2 Pharmaceutical CDMO Services Market Deals Landscape

    7 Pharmaceutical CDMO Services Raw Materials and Cost Structure Analysis

    • 7.1 Pharmaceutical CDMO Services Key Raw Materials

    • 7.2 Pharmaceutical CDMO Services Price Trend of Key Raw Materials

    • 7.3 Pharmaceutical CDMO Services Key Suppliers of Raw Materials

    • 7.4 Pharmaceutical CDMO Services Market Concentration Rate of Raw Materials

    • 7.5 Pharmaceutical CDMO Services Cost Structure Analysis

      • 7.5.1 Pharmaceutical CDMO Services Raw Materials Analysis

      • 7.5.2 Pharmaceutical CDMO Services Labor Cost Analysis

      • 7.5.3 Pharmaceutical CDMO Services Manufacturing Expenses Analysis

    8 Global Pharmaceutical CDMO Services Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pharmaceutical CDMO Services Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pharmaceutical CDMO Services Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pharmaceutical CDMO Services Market Outlook by Types and Applications to 2022

    • 9.1 Global Pharmaceutical CDMO Services Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Drug Substance Development and Manufacturing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Specialized Services Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Lab-based Services Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pharmaceutical CDMO Services Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Innovative Medicine Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Patented Drug Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Patent Expired Drug Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pharmaceutical CDMO Services Market Analysis and Outlook till 2022

    • 10.1 Global Pharmaceutical CDMO Services Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.2.2 Canada Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.2.3 Mexico Pharmaceutical CDMO Services Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.2 UK Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.3 Spain Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.4 Belgium Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.5 France Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.6 Italy Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.7 Denmark Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.8 Finland Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.9 Norway Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.10 Sweden Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.11 Poland Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.12 Russia Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.3.13 Turkey Pharmaceutical CDMO Services Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.2 Japan Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.3 India Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.4 South Korea Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.5 Pakistan Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.6 Bangladesh Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.7 Indonesia Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.8 Thailand Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.9 Singapore Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.10 Malaysia Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.11 Philippines Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.4.12 Vietnam Pharmaceutical CDMO Services Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.5.2 Colombia Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.5.3 Chile Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.5.4 Argentina Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.5.5 Venezuela Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.5.6 Peru Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.5.8 Ecuador Pharmaceutical CDMO Services Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.6.2 Kuwait Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.6.3 Oman Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.6.4 Qatar Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pharmaceutical CDMO Services Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.7.2 South Africa Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.7.3 Egypt Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.7.4 Algeria Pharmaceutical CDMO Services Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pharmaceutical CDMO Services Consumption (2017-2022)

      • 10.8.2 New Zealand Pharmaceutical CDMO Services Consumption (2017-2022)

    11 Global Pharmaceutical CDMO Services Competitive Analysis

    • 11.1 AMRI Global

      • 11.1.1 AMRI Global Company Details

      • 11.1.2 AMRI Global Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 AMRI Global Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.1.4 AMRI Global Pharmaceutical CDMO Services Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Piramal Pharma Solutions

      • 11.2.1 Piramal Pharma Solutions Company Details

      • 11.2.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.2.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Patheon NV

      • 11.3.1 Patheon NV Company Details

      • 11.3.2 Patheon NV Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Patheon NV Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.3.4 Patheon NV Pharmaceutical CDMO Services Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Aenova Group

      • 11.4.1 Aenova Group Company Details

      • 11.4.2 Aenova Group Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Aenova Group Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.4.4 Aenova Group Pharmaceutical CDMO Services Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 WuXi AppTec Group

      • 11.5.1 WuXi AppTec Group Company Details

      • 11.5.2 WuXi AppTec Group Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 WuXi AppTec Group Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.5.4 WuXi AppTec Group Pharmaceutical CDMO Services Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Strides Pharma Science Limited

      • 11.6.1 Strides Pharma Science Limited Company Details

      • 11.6.2 Strides Pharma Science Limited Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.6.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Fareva Group

      • 11.7.1 Fareva Group Company Details

      • 11.7.2 Fareva Group Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Fareva Group Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.7.4 Fareva Group Pharmaceutical CDMO Services Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Siegfried Ltd

      • 11.8.1 Siegfried Ltd Company Details

      • 11.8.2 Siegfried Ltd Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Siegfried Ltd Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.8.4 Siegfried Ltd Pharmaceutical CDMO Services Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Catalent Inc

      • 11.9.1 Catalent Inc Company Details

      • 11.9.2 Catalent Inc Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Catalent Inc Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.9.4 Catalent Inc Pharmaceutical CDMO Services Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 FAMAR Health Care Services

      • 11.10.1 FAMAR Health Care Services Company Details

      • 11.10.2 FAMAR Health Care Services Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 FAMAR Health Care Services Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.10.4 FAMAR Health Care Services Pharmaceutical CDMO Services Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Amatsigroup

      • 11.11.1 Amatsigroup Company Details

      • 11.11.2 Amatsigroup Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Amatsigroup Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.11.4 Amatsigroup Pharmaceutical CDMO Services Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Recipharm AB

      • 11.12.1 Recipharm AB Company Details

      • 11.12.2 Recipharm AB Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Recipharm AB Pharmaceutical CDMO Services Main Business and Markets Served

      • 11.12.4 Recipharm AB Pharmaceutical CDMO Services Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Pharmaceutical CDMO Services Market Outlook by Types and Applications to 2028

    • 12.1 Global Pharmaceutical CDMO Services Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Drug Substance Development and Manufacturing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Specialized Services Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Lab-based Services Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pharmaceutical CDMO Services Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Innovative Medicine Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Patented Drug Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Patent Expired Drug Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pharmaceutical CDMO Services Market Analysis and Outlook to 2028

    • 13.1 Global Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.2 UK Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.5 France Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.3 India Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pharmaceutical CDMO Services Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pharmaceutical CDMO Services

    • Figure of Pharmaceutical CDMO Services Picture

    • Table Global Pharmaceutical CDMO Services Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pharmaceutical CDMO Services Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Drug Substance Development and Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Global Specialized Services Consumption and Growth Rate (2017-2022)

    • Figure Global Lab-based Services Consumption and Growth Rate (2017-2022)

    • Figure Global Innovative Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Patented Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Patent Expired Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical CDMO Services Consumption by Country (2017-2022)

    • Table North America Pharmaceutical CDMO Services Consumption by Country (2017-2022)

    • Figure United States Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Canada Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Table Europe Pharmaceutical CDMO Services Consumption by Country (2017-2022)

    • Figure Germany Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure UK Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Spain Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure France Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Italy Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Finland Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Norway Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Poland Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Russia Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Table APAC Pharmaceutical CDMO Services Consumption by Country (2017-2022)

    • Figure China Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Japan Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure India Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Table South America Pharmaceutical CDMO Services Consumption by Country (2017-2022)

    • Figure Brazil Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Chile Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Peru Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Table GCC Pharmaceutical CDMO Services Consumption by Country (2017-2022)

    • Figure Bahrain Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Oman Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Table Africa Pharmaceutical CDMO Services Consumption by Country (2017-2022)

    • Figure Nigeria Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Table Oceania Pharmaceutical CDMO Services Consumption by Country (2017-2022)

    • Figure Australia Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)

    • Table AMRI Global Company Details

    • Table AMRI Global Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table AMRI Global Pharmaceutical CDMO Services Main Business and Markets Served

    • Table AMRI Global Pharmaceutical CDMO Services Product Portfolio

    • Table Piramal Pharma Solutions Company Details

    • Table Piramal Pharma Solutions Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Piramal Pharma Solutions Pharmaceutical CDMO Services Main Business and Markets Served

    • Table Piramal Pharma Solutions Pharmaceutical CDMO Services Product Portfolio

    • Table Patheon NV Company Details

    • Table Patheon NV Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Patheon NV Pharmaceutical CDMO Services Main Business and Markets Served

    • Table Patheon NV Pharmaceutical CDMO Services Product Portfolio

    • Table Aenova Group Company Details

    • Table Aenova Group Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aenova Group Pharmaceutical CDMO Services Main Business and Markets Served

    • Table Aenova Group Pharmaceutical CDMO Services Product Portfolio

    • Table WuXi AppTec Group Company Details

    • Table WuXi AppTec Group Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table WuXi AppTec Group Pharmaceutical CDMO Services Main Business and Markets Served

    • Table WuXi AppTec Group Pharmaceutical CDMO Services Product Portfolio

    • Table Strides Pharma Science Limited Company Details

    • Table Strides Pharma Science Limited Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Strides Pharma Science Limited Pharmaceutical CDMO Services Main Business and Markets Served

    • Table Strides Pharma Science Limited Pharmaceutical CDMO Services Product Portfolio

    • Table Fareva Group Company Details

    • Table Fareva Group Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fareva Group Pharmaceutical CDMO Services Main Business and Markets Served

    • Table Fareva Group Pharmaceutical CDMO Services Product Portfolio

    • Table Siegfried Ltd Company Details

    • Table Siegfried Ltd Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siegfried Ltd Pharmaceutical CDMO Services Main Business and Markets Served

    • Table Siegfried Ltd Pharmaceutical CDMO Services Product Portfolio

    • Table Catalent Inc Company Details

    • Table Catalent Inc Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Catalent Inc Pharmaceutical CDMO Services Main Business and Markets Served

    • Table Catalent Inc Pharmaceutical CDMO Services Product Portfolio

    • Table FAMAR Health Care Services Company Details

    • Table FAMAR Health Care Services Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table FAMAR Health Care Services Pharmaceutical CDMO Services Main Business and Markets Served

    • Table FAMAR Health Care Services Pharmaceutical CDMO Services Product Portfolio

    • Table Amatsigroup Company Details

    • Table Amatsigroup Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amatsigroup Pharmaceutical CDMO Services Main Business and Markets Served

    • Table Amatsigroup Pharmaceutical CDMO Services Product Portfolio

    • Table Recipharm AB Company Details

    • Table Recipharm AB Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Recipharm AB Pharmaceutical CDMO Services Main Business and Markets Served

    • Table Recipharm AB Pharmaceutical CDMO Services Product Portfolio

    • Figure Global Drug Substance Development and Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialized Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lab-based Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Innovative Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Patented Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Patent Expired Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical CDMO Services Consumption Forecast by Country (2022-2028)

    • Table North America Pharmaceutical CDMO Services Consumption Forecast by Country (2022-2028)

    • Figure United States Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pharmaceutical CDMO Services Consumption Forecast by Country (2022-2028)

    • Figure Germany Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pharmaceutical CDMO Services Consumption Forecast by Country (2022-2028)

    • Figure China Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pharmaceutical CDMO Services Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pharmaceutical CDMO Services Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pharmaceutical CDMO Services Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pharmaceutical CDMO Services Consumption Forecast by Country (2022-2028)

    • Figure Australia Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.